Skip to main content

Table 1 Criteria for the evaluation of clinical efficacy of clotting prevention as evaluated visually by the investigator at the study site at the end of the hemodialysis after the first session and after week 8

From: A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study

Score

Lines and bubble catcher

Dialyser

Satisfactory

0

No clots

Good, clear dialyser

1

Minimal clots

Light redness overall or only a few (< 3) and small (< 2 mm) dark red fibre bundles

Unstatisfactory

2

Moderate clotting

Moderate redness overall or several (≥ 3) small or few large (≥ 2 mm) dark red fibre bundles

 

3

Severe clotting

Total clotting of the dialyser (stop in hemodialysis, requiring change of the extracorporeal circuit).